Prise en charge des troubles neurovisuels de la sclérose en plaques

McDonald WI, Barnes D (1992) The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg psychiatry 55:747–52 Newman NJ (1998) Multiple sclerosis and related demyelinating diseases. In: Miller NR, Newman NJ (Eds), Walsh and Hoyt’s Clinical neuroophtalmology. 5th Ed. Baltimore: Williams and Wilkins The clinical profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial (1991) Arch Ophthalmol 109(12):1673–8 Frohman EM, Frohman TC, Zee DS, et al (2005) The neuroophthalmology of multiple sclerosis. Lancet Neurol 4:111–21 Uhthoff W (1870) Untersuchungen über die bei der multiplen hendsklerose vorkommenden augenströrungen. Arch psychiatr nervenkr 21:55–116 McAlpine D, Compston N (1952) Some aspects of the natural history of disseminated sclerosis. Q J Med 21(82):135–67 Perkin GD, Rose FC (1976) Uhthoff’s syndrome. Br J Ophtalmol 60:60–3 Scholl GB, Song HS, Wray SH (1991) Uhthoff’s symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis. Ann Neurol 30:180–4 Selhorst JB, Saul RF (1995) Uhthoff and his symptom. J Neuroophthalmol 15(2):63–9 Persson HE, Sachs C (1981) Visual evoked potentials elicited by pattern reversal during provoked visual impairment in multiple sclerosis. Brain 104:369–82 Shrager P (1989) Sodium channels in single demyelinated mammalian axons. Brain Res 483(1):149–54 Wildberger H, Hofmann H, Siegfried J (1987) Fluctuations of visual potential amplitudes and of contrast sensitivity in Uhthoff’s symptom. Doc Ophthalmol 65(3):357–65 Fromont A, Bénatru I, Gignoux L, et al (2010) Phénomène d’Uhthoff lié à l’effort, isolé, précédent une sclérose en plaques. Revue Neurol 166:61–5 Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124(pt11):2162–8 Diem R, Tschirne A, Bähr M (2003) Decreased amplitudes in multiple sclerosis patients with normal visual acuity: a VEP study. J Clin Neurosci 10(1):67–70 Regan D, Silver R, Murray TJ (1977) Visual acuity and contrast sensitivity in multiple sclerosis-Hidden visual loss: an auxiliary diagnostic test. Brain 100:563–79 Balcer LJ, Baier ML, Cohen JA, et al (2003) Contrast letter acuity component for the multiple sclerosis functional composite. Neurology 61:1367–73 Baier ML, Cutter GR, Rudick RA, et al (2005) Low-contrast letter acuity testing in patients with multiple sclerosis. Neurology 64:992–5 Frohman EM, Fujimoto JG, Frohman TC, et al (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–75 Sander MS, Bournot I, Lelièvre F, et al (2005) Les personnes ayant un handicap visuel. Les apports de l’enquête Handicap-Incapacité-Dépendance. Dress; études et résultats no 416. Juillet 2005 Gress J, Baumgarten M, De Horowitz A et al (1985) Functional Vision Screening Questionnaire. New York Association for the Blind (the lighthouse) Gress J, Baumgarten M (1995) Validation d’un questionnaire pour dépister les personnes âgées handicapées de la vue. Rapport de recherche déposé au PNRS, janvier 1995, pp 1–9 NEI VFQ-25 (1996) Interviewer Administered Format. Rand Corporation, Santa Monica, CA, 1996 Mangione CM, Lee PP, Pitts J, et al (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ): NEI-VFQ Field Test Investigators. Arch Ophtalmol 116:1496–504 Kupfer C (1998) Outcomes research-translating efficacy into effectiveness. Optom Vis Sci 75(4):235–6 Mangione CM, Lee PP, Gutierrez PR, et al (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119(7):1050–8 Balcer LJ, Baier ML, Kunkle AM, et al (2000) Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult Scler 6(6):382–5 Ma SL, Shea JA, Galetta SL, et al (2002) Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 133(5):686–92 Noble J, Forooghian F, Sproule M, et al (2006) Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients. Am J Ophthalmol 142(3):464–8 Wolffsohn JS, Cochrane AL (2000) Design of the Low Vision Quality-of-Life Questionnaire (LVQOL) and measuring the Outcome of Low-Vision Rehabilitation. Am J Ophthalmol 130(6):793–802 Stelmack JA, Stelmack TR, Massof RW (2002) MeasuringLow-Vision Rehabilitation Outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 43(9):2859–68 Mowry EM, Loguidice MJ, Daniels AB, et al (2009) Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 80(7):767–72 van Diemen HA, van Dongen MM, Dammers JW, Polman CH (1992) Increased visual impairment after exercise (Uhthoff’s phenomenon) in multiple sclerosis: therapeutic possibilities. Eur Neurol 32(4):231–4 Barron C (1993) Low vision rehabilitation of multiple sclerosis. J Am Optom Assoc 64(1):38–44 Stoll S, Sarma S, Hoeft WW (1995) Low vision aids training in the home. J Am Optom Assoc 66(1):32–8 Kleindschmidt JJ (1996) An orientation to vision loss program: meeting the needs of newly visually impaired older adults. Gerontologist 36(4):534–8 Raasch TW, Leat SJ, Kleinstein RN, et al (1997) Evaluating the value of low-vision services. J Am Optom Assoc 68(5):287–95